A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia
NCT04659122
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class
Stopped
Termination / study goals reached
Conditions
COVID-19
Undefined
Interventions
BIOLOGICAL:
AT-100
Sponsor
Airway Therapeutics, Inc.